Literature DB >> 15084350

Aromatase cytochrome P450 and estrogen and progesterone receptors in uterine sarcomas: correlation with clinical parameters.

Yui Kitaoka1, Jo Kitawaki, Hisato Koshiba, Shigeo Inoue, Hiroaki Ishihara, Mariko Teramoto, Hideo Honjo.   

Abstract

We examined the immunohistochemical expression of aromatase cytochrome P450 (P450arom), estrogen receptor (ER), progesterone receptor (PR), and Ki-67 in postoperative uterine sarcomas (n = 31) and the corresponding eutopic endometria (n = 20) to evaluate the relationships between the endocrine character of uterine sarcomas and the clinical features. In sarcoma tissues, P450arom was detected in 55% of cases, ER in 42%, PR in 42%, and Ki-67 in 90%. In eutopic endometria, P450arom was detected in 60% of cases, ER in 60%, and PR in 35%. There were correlations in the steroid-related proteins between the tumors and endometria (P = 0.001-0.026). The positivity of endometrial P450arom (P = 0.04) and ER (P = 0.006) was higher in surviving patients than dead patients regardless of the menstrual state. The results demonstrate correlation between the expression of P450arom, ER, and PR in tumors and eutopic endometria. Intense expression of the steroid-related proteins was associated with better survival.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084350     DOI: 10.1016/j.jsbmb.2003.11.013

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  5 in total

1.  Endometrial receptivity defects during IVF cycles with and without letrozole.

Authors:  Paul B Miller; Brent A Parnell; Greta Bushnell; Nicholas Tallman; David A Forstein; H Lee Higdon; Jo Kitawaki; Bruce A Lessey
Journal:  Hum Reprod       Date:  2012-01-13       Impact factor: 6.918

Review 2.  Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.

Authors:  Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

Review 3.  Current status of the adjuvant therapy in uterine sarcoma: A literature review.

Authors:  Alessandro Rizzo; Maria Abbondanza Pantaleo; Maristella Saponara; Margherita Nannini
Journal:  World J Clin Cases       Date:  2019-07-26       Impact factor: 1.337

Review 4.  New Insights into Hormonal Therapies in Uterine Sarcomas.

Authors:  Elena Maccaroni; Valentina Lunerti; Veronica Agostinelli; Riccardo Giampieri; Laura Zepponi; Alessandra Pagliacci; Rossana Berardi
Journal:  Cancers (Basel)       Date:  2022-02-12       Impact factor: 6.639

5.  Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors.

Authors:  Eirini Thanopoulou; Khin Thway; Komel Khabra; Ian Judson
Journal:  Clin Sarcoma Res       Date:  2014-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.